Advertisement

The Plasma Lipoproteins in Nonhuman Primates

  • V. Blaton
Part of the NATO Advanced Study Institutes Series book series (NSSA, volume 15)

Abstract

The need for satisfactory animal models arises in part from the defects of man as a model for the study of atherosclerosis. Atherosclerosic lesions in humans develop irregularly over a period of years. This makes the study of either progression or regression of the disease in humans very difficult. Animal models provide the advantage that the lesions of fairly definite age can be induced in a short period of time so that factors either aggravating them or causing their regression can be studied with reasonable accuracy. The search for a completely satisfactory animal model is not finished, but an investigator now has available information concerning a large number of models from which he can choose. While no animal model exists that duplicates perfectly the human disease and all of its effects such as myocardial or cerebral infarcts, an investigator can choose from a variety of species best suited for studies of the particular facets of the disease he is interested in.

Keywords

Control Diet Nonhuman Primate Plasma Lipoprotein Mountain Gorilla Papio Cynocephalus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    V. Blaton, H. Peeters, The non-human primates as models for studying atherosclerosis. Studies on the chimpanzee, the baboon and the rhesus maccacus. Atherosclerosis Drug Discovery Book, 67, 33 (1976).Google Scholar
  2. 2.
    J. Mortelmans, Primates Med., 2, 113 (1969).PubMedGoogle Scholar
  3. 3.
    V. Blaton, D. Vandamme, M. Vastesaeger, J. Mortelmans, H. Peeters, Dietary induced hyperbetalipoproteinemia in chimpanzees: Comparison to the human hyperlipoproteinemia, Experimental and Molecular Pathology, 20, 132 (1974).PubMedCrossRefGoogle Scholar
  4. 4.
    V. Blaton, H. Peeters, Integrated approach to plasma lipid and lipoprotein analysis, Chapter 6: in “Blood Lipids and Lipoproteins”, G.Nelson, ed., 369–431 (1971) J.Wiley and Sons, New York.Google Scholar
  5. 5.
    D. Vandamme, V. Blaton, H. Peeters, Screening of plasma lipids by thin-layer chromatography with flame ionization detection on chromarods, Journal of Chromatography, 145 (1978).Google Scholar
  6. 6.
    H. Peeters, V. Blaton, Lipid fatty acid relationship in electrochromatographic lipoprotein fractions, Prog. Biochem. Pharmacol., 4, 144–152 (1968), Karger Basel.Google Scholar
  7. 7.
    V. Blaton, H. Peeters, G.A. Gresham, A.N. Howard, Differential fatty acid composition of alpha and beta, lipoproteins in baboons Prog. Biochem. Pharmacol., 4, 122–125 (1968)Google Scholar
  8. Karger Basel. V. Blaton, R. Vercaemst, N. Vandecasteele, H. Caster, H. Peeters, Isolation and partial characterisation of chimpanzee plasma hich density lipoproteins and their apolipoproteins, Biochemistry, 13, 1127 (1974).CrossRefGoogle Scholar
  9. 9.
    V. Blaton, R. Vercaemst, M. Rosseneu, J. Mortelmans, R.L. Jackson, A.M. Gotto Jr., H. Peeters, Characterization of baboon plasma high density lipoproteins and of their major apoproteins, Biochemistry, 16, 2157 (1977).PubMedCrossRefGoogle Scholar
  10. 10.
    M. Rosseneu, V. Blaton, R. Vercaemst, F. Soetewey, H. Peeters, Phospholipid binding and self-association of the major apoprotein of human and baboon high density lipoproteins, Eur. J. Biochem., 74, 83–88 (1977).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1978

Authors and Affiliations

  • V. Blaton
    • 1
  1. 1.Simon Stevin Instituut and Department of Clinical ChemistrySt.JanshospitaalBruggeBelgium

Personalised recommendations